Linking In Vitro Intrinsic Dissolution Rate and Thermodynamic Solubility with Pharmacokinetic Profiles of Bedaquiline Long-Acting Aqueous Microsuspensions in Rats-Reference-Cited by-同舟云学术

Linking In Vitro Intrinsic Dissolution Rate and Thermodynamic Solubility with Pharmacokinetic Profiles of Bedaquiline Long-Acting Aqueous Microsuspensions in Rats

Published:2021-01-05 Issue:3 Volume:18 Page:952-965
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Nguyen Vy¹²^ORCID,Bevernage Jan³,Darville Nicolas³,Tistaert Christophe³,Van Bocxlaer Jan¹,Rossenu Stefaan²,Vermeulen An¹²

Affiliation:

1. Laboratory of Medical Biochemistry and Clinical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent B-9000, Belgium

2. Quantitative Sciences, Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse B-2340, Belgium

3. Drug Product Development, Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse B-2340, Belgium

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00948

Reference60 articles.

1. A review of tuberculosis: Focus on bedaquiline

2. Bedaquiline: a review of human pharmacokinetics and drug-drug interactions

3. Drug-like properties and the causes of poor solubility and poor permeability

4. Strategies for formulating and delivering poorly water-soluble drugs

5. Controlled drug delivery systems: Past forward and future back

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective;Molecular Pharmaceutics;2024-08-19

2. Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy;PLOS Neglected Tropical Diseases;2023-11-27

3. Role of Modeling and Simulation in Preclinical and Clinical Long-Acting Injectable Drug Development;The AAPS Journal;2023-10-17

4. Minimal effective dose of oral bedaquiline and activity of a long acting formulation of bedaquiline in the murine model of leprosy Bedaquiline for the treatment of leprosy;2023-05-18

5. Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium “Long-Acting Injectables” Working Group;Pharmaceutical Research;2023-02-22